Geneos Wealth Management’s JPMorgan Active Small Cap Value ETF JPSV Stock Holding History

Geneos Wealth Management’s Portfolio JPSV Stock Details JPSV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.92M	Sell	105,573 -3,354	-3%	-$232K	0.13%	167
2026 Q2	$7.52M	Sell	108,927 -35,008	-24%	-$2.24M	0.15%	152
2026 Q1	$8.46M	Sell	143,935 -5,316	-4%	-$321K	0.2%	118
2025 Q4	$8.66M	Buy	149,251 +10,007	+7%	+$580K	0.21%	119
2025 Q3	$8.17M	Buy	139,244 +13,400	+11%	+$782K	0.21%	128
2025 Q2	$7.09M	Buy	125,844 +69,208	+122%	+$3.77M	0.17%	146
2025 Q1	$3.14M	Buy	56,636 +10,949	+24%	+$632K	0.11%	236
2024 Q4	$2.67M	Buy	+45,687	New	+$2.78M	0.09%	243

Other funds holding JPSV

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Geneos Wealth Management's JPSV Position: Q3 2026 in Review

Geneos Wealth Management reduced its JPMorgan Active Small Cap Value ETF (JPSV) stake by 3.1% in Q3 2026, selling an estimated $232K and leaving 105,573 shares worth $6.92M. The position accounts for 0.13% of the portfolio, ranked #167.

Geneos Wealth Management first reported a position in JPSV in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.66M in Q4 2025. 2 funds tracked by Wall St. Rank hold JPSV as of Q3 2026.

Geneos Wealth Management held 105,573 shares of JPMorgan Active Small Cap Value ETF worth $6.92M as of Q3 2026.
Geneos Wealth Management sold 3,354 JPMorgan Active Small Cap Value ETF shares in Q3 2026, an estimated $232K.
JPMorgan Active Small Cap Value ETF made up 0.13% of Geneos Wealth Management's portfolio in Q3 2026, its #167 holding.
Geneos Wealth Management first reported a position in JPMorgan Active Small Cap Value ETF in Q4 2024 and has held it in 8 quarters since.
Geneos Wealth Management's JPMorgan Active Small Cap Value ETF position peaked at $8.66M in Q4 2025.
2 funds tracked by Wall St. Rank held JPMorgan Active Small Cap Value ETF as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.